当前位置:
X-MOL 学术
›
J. Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Risk of Cancer in Middle-aged Patients With Gout: A Nationwide Population-based Study in Korea.
The Journal of Rheumatology ( IF 3.6 ) Pub Date : 2021-07-01 , DOI: 10.3899/jrheum.210565 Shih-Wei Lai, Chiu-Shong Liu, Bing-Fang Hwang
The Journal of Rheumatology ( IF 3.6 ) Pub Date : 2021-07-01 , DOI: 10.3899/jrheum.210565 Shih-Wei Lai, Chiu-Shong Liu, Bing-Fang Hwang
A cohort study conducted by Lee, et al published in The Journal of Rheumatology revealed that the hazard of overall cancer was higher in patients aged 41-55 with gout than the control group in Korea (adjusted HR [aHR] 1.224, 95% CI 1.073-1.398).1 Their findings are compatible with 1 study in Korea reporting that the hazard of overall cancer was higher in patients aged ≥ 20 years with gout than the control group (aHR 1.053, 95% CI 1.031-1.077, P < 0.01).2.
中文翻译:
中年痛风患者的癌症风险:韩国的一项全国性人口研究。
Lee等人在《风湿病学杂志》上发表的一项队列研究显示,韩国 41-55 岁痛风患者的总体癌症风险高于对照组(调整后的 HR [aHR] 1.224,95% CI 1.073 -1.398)。1他们的研究结果与韩国的一项研究一致,该研究报告称 20 岁以上痛风患者的总体癌症风险高于对照组(aHR 1.053,95% CI 1.031-1.077,P < 0.01)。2 .
更新日期:2021-07-05
中文翻译:
中年痛风患者的癌症风险:韩国的一项全国性人口研究。
Lee等人在《风湿病学杂志》上发表的一项队列研究显示,韩国 41-55 岁痛风患者的总体癌症风险高于对照组(调整后的 HR [aHR] 1.224,95% CI 1.073 -1.398)。1他们的研究结果与韩国的一项研究一致,该研究报告称 20 岁以上痛风患者的总体癌症风险高于对照组(aHR 1.053,95% CI 1.031-1.077,P < 0.01)。2 .